McGill University and
Genome Quebec Innovation Centre

The McGill University and Genome Québec Innovation Centre is a world class research facility for genomics and proteomics. Founded by Dr. Tom Hudson and initially focused on complex genetic disorders such as cardiac disease and asthma, the centre has become a networking site for various research initiatives. Large scale projects include haplotyping of the human genome (HapMap) and defining the regulatory mechanisms of gene expression. High throughput genomics research is supported by three essential platforms: genotyping, sequencing and functional genomics. The proteomics platform provides high quality protein analytical services.

These platforms and the available facilities at the Innovation Centre will form the core of a fifth platform’s content and development activities. This fifth platform, pharmacogenomics, is an extension of the Genome Quebec and University of Montreal Pharmacogenomics Centre at the Montreal Heart Institute. Its goal is to improve the quality of healthcare in Quebec by identifying opportunities where genomic and proteomic technologies can be integrated into both clinical trials and the physicians’ office.

All platforms work in parallel to provide comprehensive, reliable service to investigators. On the campus of McGill University in the heart of Montreal, the Centre acts as a vast resource of knowledge and technology to the academic, industrial and commercial sectors.